Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients

Completed · Not applicable

Conditions studied: Asthma, Chronic Obstructive Pulmonary Disease

In brief

Metered Dose Inhaler (MDI) and Dry Powdered Inhaler (DPI) are the two most common devices used to deliver medicine in conditions such as asthma and chronic obstructive pulmonary disease. It is well-known that most patients do not use correct technique when using a metered dose inhaler. This leads to poor control of their disease. This study is being done so the investigators can record the patient using the metered dose inhaler before and after a short teaching session. This information will be fed into an invitro system (device) to allow the researchers to study the effect of error on drug delivery. The device being used is the Rice R3 electronic flowmeter.

Key facts

Study ID

NCT02447575

Run by

Baylor College of Medicine

People needed

23

Starts

2015-02-01

Expected to finish

2019-07-01

Last updated by the study team

2020-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a physician diagnosis of asthma or COPD taking inhaled medications using MDI
• Age >18 years
• Able to read and sign consent document

You may not qualify if…

• Patients having acute exacerbation
• Patients who are unable to take medication from an MDI

Where it is running

• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.